标题
Alternative and Experimental Therapies of Mycobacterium abscessus Infections
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 18, Pages 6793
出版商
MDPI AG
发表日期
2020-09-17
DOI
10.3390/ijms21186793
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Synergistic interactions of indole-2-carboxamides and β-lactam antibiotics against Mycobacterium abscessus
- (2020) Clément Raynaud et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus
- (2020) Rose C. Lopeman et al. Scientific Reports
- Extreme Drug Tolerance of Mycobacterium abscessus “Persisters”
- (2020) Yee-Kuen Yam et al. Frontiers in Microbiology
- Rifabutin is bactericidal against intracellular and extracellular forms of Mycobacterium abscessus
- (2020) Matt D. Johansen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline
- (2020) Charles L. Daley et al. EUROPEAN RESPIRATORY JOURNAL
- Indole-2-carboxamides are Active Against an Acute Mycobacterium abscessus Infected Mouse Model
- (2019) Amit N. Pandya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activity of the new β-lactamase inhibitors relebactam and vaborbactam in combination with β-lactams against Mycobacterium abscessus complex clinical isolates
- (2019) Amit Kaushik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Select β-Lactam Combinations Exhibit Synergy against Mycobacterium abscessus In Vitro
- (2019) Elizabeth Story-Roller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro and Intracellular Activity of Imipenem Combined with Tedizolid, Rifabutin, and Avibactam against Mycobacterium abscessus
- (2019) Eva Le Run et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro activities of omadacycline against rapidly growing mycobacteria
- (2019) Carolyn Shoen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Synergistic efficacy of β-lactam combinations against Mycobacterium abscessus pulmonary infection in mice.
- (2019) Elizabeth Story-Roller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Biofilm-associated Mycobacterium abscessus cells have altered antibiotic tolerance and surface glycolipids in Artificial Cystic Fibrosis Sputum Media.
- (2019) Augusto Cesar Hunt-Serracin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus
- (2019) Amit Kaushik et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pilot study to test inhaled nitric oxide in cystic fibrosis patients with refractory Mycobacterium abscessus lung infection
- (2019) Lea Bentur et al. Journal of Cystic Fibrosis
- Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus
- (2019) Rebekah M. Dedrick et al. NATURE MEDICINE
- Improved Performance Predicting Clarithromycin Resistance in Mycobacterium abscessus on an Independent Data Set
- (2019) Samuel Lipworth et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bedaquiline Eliminates Bactericidal Activity of β-Lactams against Mycobacterium abscessus
- (2019) Marissa Lindman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Activity of Bedaquiline and Delamanid against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates
- (2019) Dae Hun Kim et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Omadacycline: A Modernized Tetracycline
- (2019) Jason C Gallagher CLINICAL INFECTIOUS DISEASES
- Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus
- (2019) Hannelore I Bax et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Phage therapy as a renewed therapeutic approach to mycobacterial infections: a comprehensive review
- (2019) Taher Azimi et al. Infection and Drug Resistance
- Rifabutin is active against Mycobacterium abscessus in mice
- (2019) Thomas Dick et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
- (2019) Mike Marvin Ruth et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Synthesis of Avibactam Derivatives and Activity on β-Lactamases and Peptidoglycan Biosynthesis Enzymes of Mycobacteria
- (2018) Zainab Edoo et al. CHEMISTRY-A EUROPEAN JOURNAL
- In vitro activity of tedizolid against the Mycobacterium abscessus complex
- (2018) Fabrice Compain et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Activity of Rifabutin and Hemi-synthetic Derivatives Against Mycobacterium abscessus
- (2018) Ivy B. Ramis et al. Medicinal Chemistry
- Tedizolid Activity Against Clinical Mycobacterium abscessus Complex Isolates—An in vitro Characterization Study
- (2018) Ying Wei Tang et al. Frontiers in Microbiology
- A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria
- (2018) Mike Marvin Ruth et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The addition of avibactam renders piperacillin an effective treatment for Mycobacterium abscessus infection in an in vivo model
- (2018) Michal Meir et al. Antimicrobial Resistance and Infection Control
- Bedaquiline as a potential agent in the treatment of Mycobacterium abscessus infections
- (2017) Silvan Vesenbeckh et al. EUROPEAN RESPIRATORY JOURNAL
- Nitric Oxide Modulates Macrophage Responses toMycobacterium tuberculosisInfection through Activation of HIF-1α and Repression of NF-κB
- (2017) Jonathan Braverman et al. JOURNAL OF IMMUNOLOGY
- Targeting Mycolic Acid Transport by Indole-2-carboxamides for the Treatment of Mycobacterium abscessus Infections
- (2017) Alan P. Kozikowski et al. JOURNAL OF MEDICINAL CHEMISTRY
- Compassionate Nitric Oxide Adjuvant Treatment of Persistent Mycobacterium Infection in Cystic Fibrosis Patients
- (2017) Karin Yaacoby-Bianu et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Relationship between Antibiotic Susceptibility and Genotype in Mycobacterium abscessus Clinical Isolates
- (2017) Bing Li et al. Frontiers in Microbiology
- Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial
- (2017) Joseph Solomkin et al. JAMA Surgery
- Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis
- (2017) Bibhuti B. Mishra et al. Nature Microbiology
- Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic
- (2016) S. Ken Tanaka et al. BIOORGANIC & MEDICINAL CHEMISTRY
- A new piperidinol derivative targeting mycolic acid transport inMycobacterium abscessus
- (2016) Christian Dupont et al. MOLECULAR MICROBIOLOGY
- Susceptibility of Mycobacterium abscessus to Antimycobacterial Drugs in Preclinical Models
- (2015) Andrés Obregón-Henao et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Nitric Oxide Regulation of Bacterial Biofilms
- (2015) Dhruv P. Arora et al. BIOCHEMISTRY
- Preliminary Results of Bedaquiline as Salvage Therapy for Patients With Nontuberculous Mycobacterial Lung Disease
- (2015) Julie V. Philley et al. CHEST
- US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
- (2015) R Andres Floto et al. THORAX
- A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections
- (2014) Christopher P. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Analysis of the Phase 3 ESTABLISH Trials of Tedizolid versus Linezolid in Acute Bacterial Skin and Skin Structure Infections
- (2014) Andrew F. Shorr et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex
- (2014) S. Singh et al. CLINICAL MICROBIOLOGY AND INFECTION
- -Lactamase inhibition by avibactam in Mycobacterium abscessus
- (2014) V. Dubee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of broad-spectrum Mycobacterium abscessus class A -lactamase
- (2013) D. Soroka et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- New Rapid Scheme for Distinguishing the Subspecies of the Mycobacterium abscessus Group and Identifying Mycobacterium massiliense Isolates with Inducible Clarithromycin Resistance
- (2013) S. J. Shallom et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Inhaled nitric oxide decreases the bacterial load in a rat model of Pseudomonas aeruginosa pneumonia
- (2013) Christopher C. Miller et al. Journal of Cystic Fibrosis
- In Vivo Evaluation of Antibiotic Activity Against Mycobacterium abscessus
- (2013) Isabelle Lerat et al. JOURNAL OF INFECTIOUS DISEASES
- In VitroSynergy between Clofazimine and Amikacin in Treatment of Nontuberculous Mycobacterial Disease
- (2012) Jakko van Ingen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The potential of nitric oxide releasing therapies as antimicrobial agents
- (2012) David O. Schairer et al. Virulence
- Assessment of Clarithromycin Susceptibility in Strains Belonging to theMycobacterium abscessusGroup byerm(41) andrrlSequencing
- (2010) Sylvaine Bastian et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started